MedPath
FDA Approval

Etomidate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 22, 2024
Labeling Type
Human Prescription Drug Label
Etomidate(2 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Armas Pharmaceuticals Inc.

098405973

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Caplin Steriles Limited

Armas Pharmaceuticals Inc.

Armas Pharmaceuticals Inc.

650744670

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Etomidate

Product Details

NDC Product Code
72485-509
Application Number
ANDA215028
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
January 22, 2024
WATERInactive
Code: 059QF0KO0RClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
EtomidateActive
Code: Z22628B598Class: ACTIBQuantity: 2 mg in 1 mL

Etomidate

Product Details

NDC Product Code
72485-508
Application Number
ANDA215028
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
January 22, 2024
EtomidateActive
Code: Z22628B598Class: ACTIBQuantity: 2 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
© Copyright 2025. All Rights Reserved by MedPath